Breaking News, Promotions & Moves

Segmed Appoints David Gasoigne as CEO

Gasoigne succeeds Dr. Martin Willemink, M.D., Ph.D., the company's Co-founder and former CEO, who will assume the role of Chief Scientific Officer.

Author Image

By: Charlie Sternberg

Associate Editor

Segmed Inc., a leader in real-world imaging data for research and AI development, has appointed David Gascoigne as Chief Executive Officer (CEO). This leadership position marks a pivotal moment as the company accelerates its next phase of growth and innovation. Dr. Martin Willemink, M.D., Ph.D., the company’s Co-founder and former CEO, will assume the role of Chief Scientific Officer to focus on advancing the company’s scientific vision, academic collaborations, and market presenc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters